{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:57:17Z","timestamp":1792180637552,"version":"4.4.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaip.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T04:27:40Z","timestamp":1530764860000},"page":"1119-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["How to Approach Chronic Inducible Urticaria"],"prefix":"10.1016","volume":"6","author":[{"given":"Marcus","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim W.","family":"Fluhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.03.007_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1468-3083.2010.03951.x","article-title":"Physical urticaria: prevalence, type and natural course in a tropical country","volume":"25","author":"Silpa-Archa","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jdv.12661","article-title":"Symptomatic dermographism: an inadequately described disease","volume":"29","author":"Schoepke","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1067\/mjd.2001.116217","article-title":"Natural course of physical and chronic urticaria and angioedema in 220 patients","volume":"45","author":"Kozel","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2133.2002.04582.x","article-title":"The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre","volume":"146","author":"van der Valk","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archderm.134.1.106","article-title":"Clinical predictive factors of severity in cold urticaria","volume":"134","author":"Mathelier-Fusade","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0190-9622(85)70208-3","article-title":"Cold urticaria. Clinical findings in 220 patients","volume":"13","author":"Neittaanm\u00e4ki","year":"1985","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0091-6749(86)90027-8","article-title":"Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria","volume":"78","author":"Wanderer","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","article-title":"The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria","volume":"135","author":"Chang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imr.12632","article-title":"The role and relevance of mast cells in urticaria","volume":"282","author":"Church","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2018.03.007_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0091-6749(92)90297-F","article-title":"Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission","volume":"89","author":"Jacques","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0091-6749(78)90113-6","article-title":"Assessment of tissue fluid histamine levels in patients with urticaria","volume":"61","author":"Kaplan","year":"1978","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib12","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","article-title":"Autoimmune chronic spontaneous urticaria: what we know and what we don\u2018t know","volume":"139","author":"Kolkhir","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib13","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2014a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.03.007_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000336572","article-title":"Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction","volume":"224","author":"Kring Tannert","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2018.03.007_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(70)80110-3","article-title":"Cold urticaria. Immunologic studies","volume":"49","author":"Houser","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2018.03.007_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0002-9343(73)90221-0","article-title":"Dermographia mediated by immunoglobulin E","volume":"54","author":"Newcomb","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2018.03.007_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archderm.1986.01660170080024","article-title":"Solar urticaria. The relationship of photoallergen and action spectrum","volume":"122","author":"Kojima","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000246570","article-title":"Detection of action, inhibition and augmentation spectra in solar urticaria","volume":"191","author":"Miyauchi","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2018.03.007_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0091-6749(88)91008-1","article-title":"A\u00a0case study on the induction of clinical tolerance in cold urticaria","volume":"82","author":"Keahey","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2017.01.042","article-title":"Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial","volume":"140","author":"Maurer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2017.01.043","article-title":"Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial","volume":"140","author":"Metz","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ceca.2010.09.001","article-title":"TRPM8 mediates cold and menthol allergies associated with mast cell activation","volume":"48","author":"Cho","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jaip.2018.03.007_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ceca.2011.08.003","article-title":"Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria","volume":"50","author":"Medic","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jaip.2018.03.007_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11882-017-0722-1","article-title":"Review of physical urticarias and testing methods","volume":"17","author":"S\u00e1nchez-Borges","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2018.03.007_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaip.2016.09.029","article-title":"Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors","volume":"5","author":"Sanchez","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.03.007_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11882-012-0269-0","article-title":"Physical urticaria","volume":"12","author":"Abajian","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2018.03.007_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00105-004-0691-x","article-title":"Physical urticaria [in German]","volume":"55","author":"Fleischer","year":"2004","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2018.03.007_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-0240","article-title":"Urticaria: current opinions about etiology, diagnosis and therapy","volume":"87","author":"Zuberbier","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/00015555-0306","article-title":"Urticarial dermographism: clinical features and response to psychosocial stress","volume":"87","author":"Wallengren","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib31","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1111\/j.1365-2230.2008.03097.x","article-title":"Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg","volume":"34","author":"Magerl","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.1993.tb00488.x","article-title":"The effect of cetirizine on symptoms and wealing in dermographic urticaria","volume":"129","author":"Sharpe","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib33","doi-asserted-by":"crossref","unstructured":"Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber\u00a0B, et al. The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update [published online ahead of print January 15, 2018]. Allergy. https:\/\/doi.org\/10.1111\/all.13397.","DOI":"10.1111\/all.13397"},{"key":"10.1016\/j.jaip.2018.03.007_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.1979.tb15293.x","article-title":"The effect of H1 and H2 histamine antagonists on symptomatic dermographism","volume":"101","author":"Matthews","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2133.1981.tb00043.x","article-title":"Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind study","volume":"104","author":"Kaur","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2340\/0001555563260262","article-title":"The effect of H1 and H2 receptor antagonists on the dermographic response","volume":"63","author":"Cook","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1398-9995.2010.02409.x","article-title":"Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy","volume":"65","author":"Krause","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.annder.2012.01.020","article-title":"Solar urticaria [in French]","volume":"139","author":"Adamski","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaad.2008.07.016","article-title":"Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study","volume":"59","author":"Borzova","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib41","first-page":"302","article-title":"UVB treatment of factitious urticaria","volume":"4","author":"Johnsson","year":"1987","journal-title":"Photodermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2230.1989.tb00877.x","article-title":"The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographism","volume":"14","author":"Logan","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1001\/jama.1924.02660010007002","article-title":"Urticaria caused specifically by the action of physical agents:(light, cold, heat, freezing, burns, mechanical irritation, and physical and mental exertion)","volume":"83","author":"Duke","year":"1924","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2018.03.007_bib44","first-page":"429","article-title":"Cold urticaria [in French]","volume":"121","author":"Mathelier-Fusade","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib45","series-title":"UpToDate.","article-title":"Cold urticaria","author":"Maurer","year":"2018"},{"key":"10.1016\/j.jaip.2018.03.007_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/21548331.1979.11707566","article-title":"An 'allergy' to cold","volume":"14","author":"Wanderer","year":"1979","journal-title":"Hosp Pract"},{"key":"10.1016\/j.jaip.2018.03.007_bib47","first-page":"510","article-title":"Epidemiology and clinical aspects of cold urticaria [in German]","volume":"47","author":"Moller","year":"1996","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2018.03.007_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0091-6749(90)90173-2","article-title":"Essential acquired cold urticaria","volume":"85","author":"Wanderer","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010441","article-title":"Cold-induced urticaria: challenges in diagnosis and management","volume":"2013","author":"Hochstadter","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2018.03.007_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.iac.2004.01.005","article-title":"Physical urticaria","volume":"24","author":"Dice","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.03.007_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2016.05.001","article-title":"The role of the inflammasome in patients with autoinflammatory diseases","volume":"138","author":"Hoffman","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/all.12030","article-title":"How not to miss autoinflammatory diseases masquerading as urticaria","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaci.2009.09.035","article-title":"Familial atypical cold urticaria: description of a new hereditary disease","volume":"124","author":"Gandhi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2018.03.007_bib55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2340\/0001555572389","article-title":"Chronic aquagenic urticaria","volume":"72","author":"Gimenez-Arnau","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib56","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jdv.12739","article-title":"An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria","volume":"29","author":"Magerl","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib57","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jaci.2004.07.018","article-title":"Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria","volume":"114","author":"Siebenhaar","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2133.2009.09441.x","article-title":"Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria","volume":"162","author":"Mlynek","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib59","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1398-9995.2007.01500.x","article-title":"Acquired cold urticaria symptoms can be safely prevented by ebastine","volume":"62","author":"Magerl","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anai.2009.11.013","article-title":"Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria","volume":"104","author":"Metz","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0028-3932(73)90026-2","article-title":"Handedness, speech lateralization and ability","volume":"11","author":"Newcombe","year":"1973","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jaip.2018.03.007_bib62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.anai.2010.04.002","article-title":"Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis","volume":"104","author":"Weinstein","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2340\/00015555-2150","article-title":"Rupatadine 20 mg and 40 mg are effective in reducing the symptoms of chronic cold urticaria","volume":"96","author":"Abajian","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/all.12171","article-title":"Up-dosing with bilastine results in improved effectiveness in cold contact urticaria","volume":"68","author":"Krause","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib65","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2012.10822.x","article-title":"Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1)-antihistamine dose escalation","volume":"166","author":"Magerl","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2340\/00015555-1918","article-title":"Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study","volume":"95","author":"Martinez-Escala","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib67","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib68","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaci.2006.04.003","article-title":"Successful treatment of cold-induced urticaria\/anaphylaxis with anti-IgE","volume":"117","author":"Boyce","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000346284","article-title":"Treatment of severe cold contact urticaria with omalizumab: case reports","volume":"4","author":"Brodska","year":"2012","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib70","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2012.10.026","article-title":"Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases","volume":"69","author":"Le Moing","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjd.14820","article-title":"Patients with chronic cold urticaria may benefit from doxycycline therapy","volume":"176","author":"Gorczyza","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib72","first-page":"40","article-title":"Cold urticaria-'desensitisation'","volume":"60","author":"Leigh","year":"1974","journal-title":"Trans St Johns Hosp Dermatol Soc"},{"key":"10.1016\/j.jaip.2018.03.007_bib73","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaci.2018.01.031","article-title":"Chronic inducible urticaria: a systematic review of treatment options","volume":"141","author":"Dressler","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 6","key":"10.1016\/j.jaip.2018.03.007_bib74","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF01659741","article-title":"Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl) [in German]","volume":"7","author":"Illig","year":"1979","journal-title":"Infection"},{"key":"10.1016\/j.jaip.2018.03.007_bib75","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2007.08109.x","article-title":"Cold urticaria: tolerance induction with cold baths","volume":"157","author":"von Mackensen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/000155500750043168","article-title":"Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast","volume":"80","author":"Hani","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/S0190-9622(03)01590-1","article-title":"Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination","volume":"49","author":"Bonadonna","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2003.05414.x","article-title":"Cold urticaria responding to systemic ciclosporin","volume":"149","author":"Marsland","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib79","first-page":"302","article-title":"Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)","volume":"67","author":"Bodar","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaip.2018.03.007_bib80","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1365-2133.2011.10797.x","article-title":"Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis","volume":"166","author":"Gualdi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib81","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555565449450","article-title":"Ultraviolet light therapy in chronic urticaria","volume":"65","author":"Hannuksela","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib82","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/jdv.14594","article-title":"Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria","volume":"32","author":"Maurer","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.iac.2013.09.010","article-title":"Physical urticarias and cholinergic urticaria","volume":"34","author":"Abajian","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.03.007_bib84","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0091-6749(05)80136-8","article-title":"Ketotifen in cholinergic urticaria","volume":"86","author":"Czarnetzki","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00502986","article-title":"On the pathogenesis of cholinergic urticaria. I. Clinical observations and histological studies [in German]","volume":"229","author":"Illig","year":"1967","journal-title":"Arch Klin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib86","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00502991","article-title":"On the pathogenesis of cholinergic urticaria. II. Studies on the relationships of cholinergic urticaria to sweat secretions with the help of various cholinomimetics [in German]","volume":"229","author":"Illig","year":"1967","journal-title":"Arch Klin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib87","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00509212","article-title":"On the pathogenesis of cholinergic urticaria. 3. The influence of sweat secretion inhibition on cholinergic urticaria [in German]","volume":"229","author":"Illig","year":"1967","journal-title":"Arch Klin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib88","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00509213","article-title":"On the pathogenesis of cholinergic urticaria. IV. On the problem of a true antigen-antibody reaction [in German]","volume":"229","author":"Illig","year":"1967","journal-title":"Arch Klin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00495999","article-title":"Pathogenesis of cholinergic urticaria. V. The pharmacologic reactivity of the Prausnitz-Kustner reaction and the origin of the antigen [in German]","volume":"230","author":"Illig","year":"1967","journal-title":"Arch Klin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib90","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014The EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1249\/JSR.0000000000000111","article-title":"Cholinergic urticaria and exercise-induced anaphylaxis","volume":"14","author":"Montgomery","year":"2015","journal-title":"Curr Sports Med Rep"},{"key":"10.1016\/j.jaip.2018.03.007_bib92","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/jdv.13765","article-title":"Atopic predisposition in cholinergic urticaria patients and its implications","volume":"30","author":"Altrichter","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib93","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cea.13023","article-title":"Cholinergic urticaria patients of different age groups have distinct features","volume":"47","author":"Asady","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib94","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2014.04.007","article-title":"Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria","volume":"75","author":"Altrichter","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2018.03.007_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cea.13102","article-title":"Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL)","volume":"48","author":"Ruft","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/0001555575147149","article-title":"Efficacy of cetirizine in cholinergic urticaria","volume":"75","author":"Zuberbier","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib97","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000246281","article-title":"Double-blind crossover study of high-dose cetirizine in cholinergic urticaria","volume":"193","author":"Zuberbier","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2018.03.007_bib98","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jaci.2016.05.026","article-title":"Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria","volume":"138","author":"Koch","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib99","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4103\/0366-6999.157703","article-title":"Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints","volume":"128","author":"Kutlu","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jaip.2018.03.007_bib100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.03.007_bib101","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2230.2006.02117.x","article-title":"Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines","volume":"31","author":"Ujiie","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib102","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1346-8138.12765","article-title":"Successful treatment of cholinergic urticaria with methantheliniumbromide","volume":"42","author":"Altrichter","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib103","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7205\/MILMED.173.2.217","article-title":"Successful treatment of disabling cholinergic urticaria","volume":"173","author":"Feinberg","year":"2008","journal-title":"Mil Med"},{"key":"10.1016\/j.jaip.2018.03.007_bib104","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bjd.12200","article-title":"Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis","volume":"168","author":"Sheraz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2332\/allergolint.10-OA-0269","article-title":"Rapid desensitization with autologous sweat in cholinergic urticaria","volume":"60","author":"Kozaru","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2018.03.007_bib106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1468-3083.2011.04017.x","article-title":"Cholinergic urticaria: pathogenesis-based categorization and its treatment options","volume":"26","author":"Nakamizo","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.03.007_bib107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2133.1989.tb01804.x","article-title":"Cholinergic pruritus, erythema and urticaria: a disease spectrum responding to danazol","volume":"121","author":"Berth-Jones","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib108","first-page":"664","article-title":"Severe refractory cholinergic urticaria treated with danazol","volume":"5","author":"La Shell","year":"2006","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib109","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2133.1987.tb05877.x","article-title":"Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria","volume":"116","author":"Wong","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2004.01.006","article-title":"Delayed pressure urticaria","volume":"24","author":"Lawlor","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.03.007_bib111","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0190-9622(93)70273-V","article-title":"Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria","volume":"29","author":"Barlow","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0091-6749(99)70506-3","article-title":"Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria","volume":"103","author":"Hermes","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2133.1968.tb12334.x","article-title":"Delayed pressure urticaria","volume":"80","author":"Ryan","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib115","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2006.12.658","article-title":"Successful treatment of delayed pressure urticaria with anti-TNF-alpha","volume":"119","author":"Magerl","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib116","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60462-0","article-title":"Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib117","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1081-1206(10)60047-6","article-title":"Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib118","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/ced.12851","article-title":"Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram","volume":"41","author":"Eskeland","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib119","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/dth.12266","article-title":"Delayed pressure urticaria: response to treatment with sulfasalazine in a case series of seventeen patients","volume":"28","author":"Swerlick","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2018.03.007_bib120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2230.2011.04281.x","article-title":"Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria","volume":"37","author":"Samarasinghe","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib121","first-page":"908","article-title":"Delayed pressure urticaria - dapsone heading for first-line therapy?","volume":"9","author":"Grundmann","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2018.03.007_bib122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2230.2005.02014.x","article-title":"Delayed pressure urticaria controlled by tranexamic acid","volume":"31","author":"Shedden","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib123","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/039463200501800320","article-title":"Theophylline as \"add-on\" therapy in patients with delayed pressure urticaria: a prospective self-controlled study","volume":"18","author":"Kalogeromitros","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2018.03.007_bib124","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2133.2003.05486.x","article-title":"Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria","volume":"149","author":"Dawn","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.03.007_bib125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mai.2003.1559","article-title":"Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria","volume":"112","author":"Nettis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaip.2016.07.016","article-title":"Rapid response to omalizumab in 3 cases of delayed pressure urticaria","volume":"5","author":"Quintero","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.03.007_bib127","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.03.007_bib128","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2017.04.050","article-title":"Responsiveness and minimal important difference of the urticaria control test","volume":"140","author":"Ohanyan","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818302654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818302654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:45Z","timestamp":1761974145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818302654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213219818302654"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.03.007","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to Approach Chronic Inducible Urticaria","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}